Literature DB >> 26719328

Activated ErbB3 Translocates to the Nucleus via Clathrin-independent Endocytosis, Which Is Associated with Proliferating Cells.

Raymond Reif1, Alshaimaa Adawy2, Nachiket Vartak2, Jutta Schröder3, Georgia Günther2, Ahmed Ghallab4, Marcus Schmidt5, Wiebke Schormann6, Jan G Hengstler2.   

Abstract

Members of the receptor tyrosine kinase family (RTK) have been shown to be present in the nucleus of cells; however, the mechanisms underlying their trafficking to the nucleus, and their relevance once there are poorly understood. In the present study, we focus on the RTK ErbB3 and elucidate the mechanisms regulating its trafficking. We show that heregulin-stimulation induces trafficking of phosphorylated ErbB3 from the plasma membrane to the nucleus via a clathrin-independent mechanism. Nuclear import of ErbB3 occurs via importin β1, which drives the receptor through the nuclear pore complex. In the nucleus, ErbB3 interacts with transcription complexes, and thereby has a role in transcriptional regulation. Our results also demonstrate that ErbB3 nuclear localization is transient as it is exported out of the nucleus by the nuclear receptor protein crm-1. Analysis of normal, regenerating tissues, and tumors showed that ErbB3 nuclear translocation is a common event in proliferating tissues.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  nuclear translocation; proliferation; receptor endocytosis; receptor tyrosine kinase; signal transduction

Mesh:

Substances:

Year:  2015        PMID: 26719328      PMCID: PMC4759164          DOI: 10.1074/jbc.M115.686782

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Localization of neuregulin isoforms and erbB receptors in myelinating glial cells.

Authors:  Timothy D Raabe; Gail Deadwyler; Jonathan W Varga; George H Devries
Journal:  Glia       Date:  2004-01-15       Impact factor: 7.452

Review 2.  Dynamic nuclear pore complexes: life on the edge.

Authors:  Elizabeth J Tran; Susan R Wente
Journal:  Cell       Date:  2006-06-16       Impact factor: 41.582

3.  Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON.

Authors:  Hong-Yi Chang; Hsiao-Sheng Liu; Ming-Derg Lai; Yuh-Shyan Tsai; Tzong-Shin Tzai; Hong-Ling Cheng; Nan-Haw Chow
Journal:  Cancer Res       Date:  2014-06-05       Impact factor: 12.701

4.  A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation.

Authors:  Masashi Narita; Masako Narita; Valery Krizhanovsky; Sabrina Nuñez; Agustin Chicas; Stephen A Hearn; Michael P Myers; Scott W Lowe
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

5.  Expression and nuclear localization of ErbB3 in prostate cancer.

Authors:  Ismaël Hervé Koumakpayi; Jean-Simon Diallo; Cécile Le Page; Laurent Lessard; Martin Gleave; Louis R Bégin; Anne-Marie Mes-Masson; Fred Saad
Journal:  Clin Cancer Res       Date:  2006-05-01       Impact factor: 12.531

6.  HER3 is a determinant for poor prognosis in melanoma.

Authors:  Markus Reschke; Daniela Mihic-Probst; Edward Htun van der Horst; Pjotr Knyazev; Peter J Wild; Markus Hutterer; Stefanie Meyer; Reinhard Dummer; Holger Moch; Axel Ullrich
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

7.  The humoral immune system has a key prognostic impact in node-negative breast cancer.

Authors:  Marcus Schmidt; Daniel Böhm; Christian von Törne; Eric Steiner; Alexander Puhl; Henryk Pilch; Hans-Anton Lehr; Jan G Hengstler; Heinz Kölbl; Mathias Gehrmann
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

8.  c-erbB-3: a nuclear protein in mammary epithelial cells.

Authors:  Martin Offterdinger; Christian Schöfer; Klara Weipoltshammer; Thomas W Grunt
Journal:  J Cell Biol       Date:  2002-06-03       Impact factor: 10.539

Review 9.  Endocytosis unplugged: multiple ways to enter the cell.

Authors:  Sudha Kumari; Swetha Mg; Satyajit Mayor
Journal:  Cell Res       Date:  2010-02-02       Impact factor: 25.617

10.  Immunoglobulin kappa chain as an immunologic biomarker of prognosis and chemotherapy response in solid tumors.

Authors:  Marcus Schmidt; Patrick Micke; Mathias Gehrmann; Jan G Hengstler
Journal:  Oncoimmunology       Date:  2012-10-01       Impact factor: 8.110

View more
  17 in total

1.  NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors.

Authors:  Takahito M Miyake; Sunila Pradeep; Emine Bayraktar; Elaine Stur; Katelyn F Handley; Sherry Y Wu; Cristian Rodriguez-Aguayo; Ju-Seog Lee; Gabriel Lopez-Berestein; Robert L Coleman; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2020-06-04       Impact factor: 6.261

Review 2.  KRASG12R-Independent Macropinocytosis in Pancreatic Cancer.

Authors:  G Aaron Hobbs; Channing J Der
Journal:  Subcell Biochem       Date:  2022

3.  An HER3-targeting antibody-drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC.

Authors:  Kimio Yonesaka; Naoki Takegawa; Satomi Watanabe; Koji Haratani; Hisato Kawakami; Kazuko Sakai; Yasutaka Chiba; Naoyuki Maeda; Takashi Kagari; Kenji Hirotani; Kazuto Nishio; Kazuhiko Nakagawa
Journal:  Oncogene       Date:  2018-10-09       Impact factor: 9.867

Review 4.  Revealing macropinocytosis using nanoparticles.

Authors:  Nicolas Means; Chandra Kumar Elechalawar; Wei R Chen; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Mol Aspects Med       Date:  2021-07-16

Review 5.  Thirty Years of HER3: From Basic Biology to Therapeutic Interventions.

Authors:  Heidi M Haikala; Pasi A Jänne
Journal:  Clin Cancer Res       Date:  2021-02-19       Impact factor: 12.531

Review 6.  Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia.

Authors:  Laurel E Black; Jody F Longo; Steven L Carroll
Journal:  Am J Pathol       Date:  2019-07-25       Impact factor: 5.770

7.  Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression.

Authors:  Domenico Trombetta; Paolo Graziano; Aldo Scarpa; Angelo Sparaneo; Giulio Rossi; Antonio Rossi; Massimo Di Maio; Davide Antonello; Andrea Mafficini; Federico Pio Fabrizio; Maria Carmina Manzorra; Teresa Balsamo; Flavia Centra; Michele Simbolo; Angela Pantalone; Michela Notarangelo; Paola Parente; Maria Cecilia Lucia Dimitri; Antonio Bonfitto; Fabiola Fiordelisi; Clelia Tiziana Storlazzi; Alberto L'Abbate; Marco Taurchini; Evaristo Maiello; Vito Michele Fazio; Lucia Anna Muscarella
Journal:  Oncotarget       Date:  2018-01-03

8.  ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1).

Authors:  Dane A Hayes; Dale A Kunde; Robyn L Taylor; Stephen B Pyecroft; Sukhwinder Singh Sohal; Elizabeth T Snow
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

Review 9.  miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition.

Authors:  Siti A Sulaiman; Nurul-Syakima Ab Mutalib; Rahman Jamal
Journal:  Front Pharmacol       Date:  2016-08-23       Impact factor: 5.810

Review 10.  Macropinocytosis Exploitation by Cancers and Cancer Therapeutics.

Authors:  Kevin D Ha; Scott M Bidlingmaier; Bin Liu
Journal:  Front Physiol       Date:  2016-09-12       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.